MET and ovarian carcinoma: To determine whether the expression levels of miR-199a-3p and c-Met are inversely correlated in ovarian cancer cells, c-Met expression was assessed by immunohistochemistry using the same FFPE samples as used for the initial characterization of miR-199a-3p expression.